Patents by Inventor Robert BARROW
Robert BARROW has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).
-
Publication number: 20230346645Abstract: A method of dosing a psychedelic that avoids the side effects of hallucinations and perceptual disturbances by administering the psychedelic to an individual in a titrating dosing regimen and reducing side effects of hallucinations and perceptual disturbances. A kit for administering a titrating dosing regimen of a psychedelic, including a pharmaceutically effective amount of the psychedelic in dosage forms separated in packaging according to dose and time of administration in a titrating dosing regimen, and instructions for use. A method of treating an individual with psychedelics, by administering the psychedelic to the individual having a condition or disease in a titrating dosing regimen and reducing side effects of hallucinations and perceptual disturbances during treatment.Type: ApplicationFiled: May 1, 2022Publication date: November 2, 2023Applicant: Mind Medicine, Inc.Inventors: Robert Barrow, Daniel R. Karlin
-
Publication number: 20230310368Abstract: A composition for use in psychotherapeutic or medical treatment of an R(?) enantiomer of MDMA or MDA. A method of treating an individual for a medical condition (especially autism and social anxiety disorders), by administering an effective amount of a composition of an R(?) enantiomer of MDMA or MDA and treating the individual. A method of reducing neurotoxicity of MDMA and MDA, by administering an effective amount of a composition of an R(?) enantiomer of MDMA or MDA to an individual and reducing neurotoxicity of MDMA or MDA while treating the individual. A method of reducing hyperthermia of MDMA and MDA. A method of reducing physical dependence or abuse liability of MDMA and MDA.Type: ApplicationFiled: June 8, 2023Publication date: October 5, 2023Applicant: Mind Medicine, Inc.Inventors: Robert BARROW, Daniel R. Karlin, Gennady N. Smagin
-
Publication number: 20230301985Abstract: A method of treating movement disorders, by administering an effective amount of a psychedelic to an individual having a movement disorder, and treating the movement disorder.Type: ApplicationFiled: May 16, 2023Publication date: September 28, 2023Applicant: Mind Medicine, Inc.Inventors: Robert BARROW, Daniel R. KARLIN, Gennady SMAGIN
-
Publication number: 20230285359Abstract: A composition of psilocin that is stable including at least one agent or chemical modification that provides enhanced stability. A method making stable psilocin, by providing a formulation of psilocin including at least one agent or chemical modification that provides enhanced stability. A method of treatment of a disease or condition, by administering a composition of psilocin that is stable to an individual and treating the disease or condition.Type: ApplicationFiled: May 31, 2023Publication date: September 14, 2023Applicant: Mind Medicine, Inc.Inventors: Robert BARROW, Peter MACK, Stephen SCHNEIDER, Jon SCHROEDER, Gerald S. JONES
-
Publication number: 20230226019Abstract: A composition for use in psychotherapeutic or medical treatment of an R(?) enantiomer of MDMA or MDA. A method of treating an individual for a medical condition (especially autism and social anxiety disorders), by administering an effective amount of a composition of an R(?) enantiomer of MDMA or MDA and treating the individual. A method of reducing neurotoxicity of MDMA and MDA, by administering an effective amount of a composition of an R(?) enantiomer of MDMA or MDA to an individual and reducing neurotoxicity of MDMA or MDA while treating the individual. A method of reducing hyperthermia of MDMA and MDA. A method of reducing physical dependence or abuse liability of MDMA and MDA.Type: ApplicationFiled: March 20, 2023Publication date: July 20, 2023Applicant: Mind Medicine, Inc.Inventors: Robert BARROW, Daniel R. KARLIN
-
Publication number: 20230226020Abstract: A composition for use in psychotherapeutic or medical treatment of an R(?) enantiomer of MDMA or MDA. A method of treating an individual for a medical condition (especially autism and social anxiety disorders), by administering an effective amount of a composition of an R(?) enantiomer of MDMA or MDA and treating the individual. A method of reducing neurotoxicity of MDMA and MDA, by administering an effective amount of a composition of an R(?) enantiomer of MDMA or MDA to an individual and reducing neurotoxicity of MDMA or MDA while treating the individual. A method of reducing hyperthermia of MDMA and MDA. A method of reducing physical dependence or abuse liability of MDMA and MDA.Type: ApplicationFiled: March 20, 2023Publication date: July 20, 2023Applicant: Mind Medicine, Inc.Inventors: Robert BARROW, Daniel R. KARLIN
-
Publication number: 20230053429Abstract: A method of analyzing a patient's mental state, by automatically processing, integrating, and analyzing text-based and audio-based sources from the patient and clinical staff, and generating real-time outcomes and predictions. A system for processing, analyzing, and managing a patient's input including a data pool, model HUB, search service, topic modeling service, mental health related prediction service, and analytics all in electronic communication. A method of analyzing a patient, by processing, analyzing, and managing a patient's and clinical staff's text and audio input, and informing and augmenting diagnostic and prognostic processes, identifying improvement and deterioration of a patient's mental state, and identifying adverse events in psychotherapy, counseling, and other mental health management activities. A system for processing, analyzing, and managing clinical and diagnostic texts, and audio transcripts.Type: ApplicationFiled: August 17, 2022Publication date: February 23, 2023Applicant: Mind Medicine, Inc.Inventors: Adam KOLAR, Martin MAJERNIK, Miguel Amavel dos Santos PINHEIRO, Daniel R. KARLIN, Robert BARROW
-
Publication number: 20230000431Abstract: A system for monitoring patients during a consciousness-altering therapeutic treatment session including a data collection module in electronic communication with network servers for storage of data on non-transitory computer readable media for monitoring a patient's well-being during and after the treatment session. A method of using the system in treating a patient, by continuously, continually, or at the healthcare professionals discretion monitoring the well-being of the patient during a consciousness-altering therapeutic treatment session through one or more wearable devices and a patient mobile device in electronic communication with a facilitator mobile device, and continuously monitoring the well-being of the patient after the treatment session with the wearable device.Type: ApplicationFiled: June 13, 2022Publication date: January 5, 2023Applicant: Mind Medicine, Inc.Inventors: Martin MAJERNIK, Daniel R. KARLIN, Robert BARROW, Peter DUBEC
-
Publication number: 20220409628Abstract: A method of treating obesity, by administering an effective amount of a composition chosen from the group consisting of 18-methoxycoronaridine (18-MC), salts thereof, tartrates thereof, solvates thereof, isomers thereof, analogs thereof, homologues thereof, and deuterated forms thereof to an individual and treating obesity. A method of treating binge eating, by administering an effective amount of the composition to an individual and treating binge eating. A method of treating behavioral addictions, by administering an effective amount of the composition to an individual and treating the behavioral addiction.Type: ApplicationFiled: June 8, 2022Publication date: December 29, 2022Applicant: Mind Medicine, Inc.Inventors: Robert BARROW, Daniel R. KARLIN
-
Publication number: 20220395499Abstract: A composition for treating an individual while reducing acute effects, including effective amounts of a psychedelic drug and a duration shortening agent. A method of treating an individual with a psychedelic drug and reducing or eliminating its acute duration of action, by administering a psychedelic drug to the individual, administering a duration shortening agent to the individual, and shortening and/or reducing and/or eliminating the acute effects of the psychedelic drug. A method of stopping the acute duration of action of a psychedelic drug in an individual, by administering a duration shortening agent to the individual after the individual has taken a psychedelic drug and stopping the acute effects of the psychedelic drug. A method of stopping psychosis due to psychedelic administration, by administering a duration shortening agent to the individual after the individual has taken a psychedelic drug, and stopping psychosis caused by the psychedelic drug.Type: ApplicationFiled: June 6, 2022Publication date: December 15, 2022Applicant: Mind Medicine, Inc.Inventors: Daniel R. KARLIN, Robert BARROW
-
Publication number: 20220370413Abstract: A composition of psilocin that is stable including at least one agent or chemical modification that provides enhanced stability. A method making stable psilocin, by providing a formulation of psilocin including at least one agent or chemical modification that provides enhanced stability. A method of treatment of a disease or condition, by administering a composition of psilocin that is stable to an individual and treating the disease or condition.Type: ApplicationFiled: August 8, 2022Publication date: November 24, 2022Applicant: Mind Medicine, Inc.Inventors: Robert BARROW, Peter MACK, Stephen SCHNEIDER, Jon SCHROEDER, Gerald S. JONES, JR.
-
Publication number: 20220362237Abstract: A method of treating pain, by administering an effective amount of a psychedelic to an individual and treating pain in the individual. A method of treating a pain syndrome, by administering an effective amount of a psychedelic to an individual, and providing a central effect, an effect on depression, and an inflammatory effect.Type: ApplicationFiled: July 29, 2022Publication date: November 17, 2022Applicant: Mind Medicine, Inc.Inventors: Robert BARROW, Daniel R KARLIN
-
Publication number: 20220354822Abstract: A composition for use in psychotherapeutic or medical treatment of an R(?) enantiomer of MDMA or MDA. A method of treating an individual for a medical condition (especially autism and social anxiety disorders), by administering an effective amount of a composition of an R(?) enantiomer of MDMA or MDA and treating the individual. A method of reducing neurotoxicity of MDMA and MDA, by administering an effective amount of a composition of an R(?) enantiomer of MDMA or MDA to an individual and reducing neurotoxicity of MDMA or MDA while treating the individual. A method of reducing hyperthermia of MDMA and MDA. A method of reducing physical dependence or abuse liability of MDMA and MDA.Type: ApplicationFiled: May 1, 2022Publication date: November 10, 2022Applicant: Mind Medicine, Inc.Inventors: Robert BARROW, Daniel R. KARLIN
-
Publication number: 20220354862Abstract: A composition of a psychedelic in a liposome formulation, wherein the composition provides preferential distribution of the psychedelic at the CNS and blood, and reduced distribution at peripheral organs. A method of treating a patient, by administering a composition of a psychedelic in a liposome formulation to the patient, and preferentially distributing the psychedelic at the CNS with a reduced exposure in target peripheral organs (e.g., heart).Type: ApplicationFiled: April 29, 2022Publication date: November 10, 2022Applicant: Mind Medicine, Inc.Inventors: Robert BARROW, Gennady N. SMAGIN
-
Publication number: 20220354831Abstract: A method of treating movement disorders, by administering an effective amount of a psychedelic to an individual having a movement disorder, and treating the movement disorder.Type: ApplicationFiled: May 1, 2022Publication date: November 10, 2022Applicant: Mind Medicine, Inc.Inventors: Robert BARROW, Daniel R. KARLIN
-
Publication number: 20220347195Abstract: A method of treating pain, by administering an effective amount of a psychedelic to an individual and treating pain in the individual.Type: ApplicationFiled: April 29, 2022Publication date: November 3, 2022Applicant: Mind Medicine, Inc.Inventors: Robert BARROW, Daniel R KARLIN
-
Publication number: 20220280482Abstract: A composition of psilocin that is stable including at least one agent or chemical modification that provides enhanced stability. A method making stable psilocin, by providing a formulation of psilocin including at least one agent or chemical modification that provides enhanced stability. A method of treatment of a disease or condition, by administering a composition of psilocin that is stable to an individual, and treating the disease or condition.Type: ApplicationFiled: March 4, 2022Publication date: September 8, 2022Applicant: Mind Medicine, Inc.Inventors: Robert BARROW, Peter MACK, Stephen SCHNEIDER, Jon SCHROEDER
-
Patent number: 5669691Abstract: An inpavement light fixture for mounting in an airport runway or a taxiway having a cover with a flat surface and one or two windows for the passage of a light beam. An optical prism is detachably mounted in a cavity formed in the cover beside and beneath each window. The prism has three flat sides forming an equilateral triangle with two of the sides sloping upwardly to a top edge positioned at a top of its window. A special sealing member fits over the prism and preferably covers one of the two sides which slope upwardly. This member extends about a lower portion of the prism and forms a water tight seal. An electric light is mounted in a bottom receptacle on which the cover is supported. A light channel is formed in the top of the cover and extends from each window towards an edge of the cover. This channel has a bottom which slopes at a small angle to the flat top.Type: GrantFiled: February 21, 1995Date of Patent: September 23, 1997Assignee: Tristar Electric Inc.Inventor: Fred Robert Barrow